Product Wiki · Recalls · Health Canada — Medical Devices

HITACHI HICO Creatinine Jaffe Method, CREJ2 cobas (c 111, c 701/702… — recall 59045

Health Canada — Medical Devices · Canada · 2019-03-01 · Type III

As described by Health Canada — Medical Devices: HITACHI HICO Creatinine Jaffe Method, CREJ2 cobas (c 111, c 701/702, c 311/501/502), OCBAS INTEGRA 400 plus (2019-01-16)

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
59045
Date of alert
2019-03-01
Country / jurisdiction
Canada
Risk level
Type III
Risk type
recall
Product category
Medical devices
Product type
Medical devices
Reported risk: Creatinine Jaffe was found to interfere with glucose, pyruvate and ascorbate. No interference was found for the creatinine enzymatic assays on all platforms.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/hitachi-hico-creatinine-jaffe-

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.